These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19731557)

  • 1. HIV and the liver.
    Rockstroh J
    J HIV Ther; 2009 Mar; 14(1):2-3. PubMed ID: 19731557
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Cicconi et al. 'Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?'.
    Núñez M
    AIDS; 2007 Jul; 21(12):1660. PubMed ID: 17630570
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment.
    Vallet-Pichard A; Pol S
    J Hepatol; 2004 Jul; 41(1):156-66. PubMed ID: 15246224
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy.
    Tuma P; Medrano J; Resino S; Vispo E; Madejón A; Sánchez-Piedra C; Rivas P; Labarga P; Martín-Carbonero L; Barreiro P; Soriano V
    Antivir Ther; 2010; 15(6):881-6. PubMed ID: 20834100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/hepatitis C virus and HIV/hepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemia.
    Diong C; Raboud J; Li M; Cooper C;
    HIV Med; 2011 Aug; 12(7):403-11. PubMed ID: 21244600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of advanced HIV disease in patients with tuberculosis or hepatitis co-infection.
    Nelson M; Lipman M
    Int J Clin Pract; 2006 Aug; 60(8):976-83. PubMed ID: 16893439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV therapy: toxic liver injuries caused by protease inhibitors?].
    Kunde K
    Dtsch Med Wochenschr; 2000 Mar; 125(12):A12-3. PubMed ID: 10777343
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality in patients coinfected with hepatitis B virus and HIV: could antiretroviral therapy make a difference?
    Jain MK
    Clin Infect Dis; 2009 Jun; 48(12):1772-4. PubMed ID: 19435435
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current treatment of HIV infection ].
    Cahn P; Benchetrit G; Laplumé H
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S41-3; discussion S74-82. PubMed ID: 16862857
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa.
    Cooper CL; Mills E; Wabwire BO; Ford N; Olupot-Olupot P
    Int J Infect Dis; 2009 May; 13(3):302-6. PubMed ID: 19004656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Active prevention and treatment of superinfection with HBV, HCV and HIV].
    Zhuang H; Zhou YH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):294-5. PubMed ID: 15498237
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B or hepatitis C and human immunodeficiency virus infection.
    Thimme R; Spangenberg HC; Blum HE
    J Hepatol; 2005; 42 Suppl(1):S37-44. PubMed ID: 15777571
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathogenesis of liver disease in the setting of HIV-hepatitis B virus coinfection.
    Iser DM; Lewin SR
    Antivir Ther; 2009; 14(2):155-64. PubMed ID: 19430090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus and human immunodeficiency virus: the un-won battle.
    García-Samaniego J; Forns X
    Hepatology; 2007 Sep; 46(3):611-4. PubMed ID: 17879358
    [No Abstract]   [Full Text] [Related]  

  • 15. Disorders of iron metabolism associated with protease inhibitor therapy.
    McNabb JC; Cappa JA; Ross JW
    Clin Infect Dis; 2001 Aug; 33(3):413-4. PubMed ID: 11438916
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.
    Bani-Sadr F; Miailhes P; Rosenthal E; Yazdanpanah Y; Boyer L; Zucman D; Cacoub P; Perronne C; Pol S; Carrat F;
    AIDS; 2008 Jun; 22(10):1234-6. PubMed ID: 18525274
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus.
    Soriano V; Martín-Carbonero L; García-Samaniego J; Puoti M
    Clin Infect Dis; 2001 Nov; 33(10):1793-5. PubMed ID: 11641832
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
    Soriano V; Rivas P; Nuñez M
    Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Latin American guideline for the treatment of chronic hepatitis B].
    Daruich J; Gadano A; Fainboim H; Pessoa M; Cheinquer H
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):168-77. PubMed ID: 17955728
    [No Abstract]   [Full Text] [Related]  

  • 20. What drives hepatitis B virus-related hepatic flares? Virus, T cells--or a bit of both?
    McGovern B
    Clin Infect Dis; 2004 Jul; 39(1):133-5. PubMed ID: 15206065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.